The investment opportunity

Position Early. Earn from Day One.

Regulatory Note & Risk Factors

Monerys is structured under Swiss corporate law and operates in alignment with strict FINMA-aligned audit, financial, and compliance protocols. The future bank will be licensed and supervised by FINMA (Swiss Financial Market Supervisory Authority), pending final approval.

This offering is a private placement, available exclusively to:

Accredited and institutional investors Investors who meet jurisdictional and regulatory requirements

Parties who acknowledge the full Private Placement Memorandum (PPM)

Key risk factors include:

• Timeline uncertainty around FINMA licensing

• Execution risks during the infrastructure build phase

• Market volatility and changes in regulatory posture

⚠️ Please consult the full PPM before making any capital commitments.

seamless-colorful-background-geometric-modern-pattern.jpg

The Investment Opportunity
Capital Raise Overview

We Are Raising CHF 60m To Complete The Monerys Build

CHF 21M → Core banking infrastructure, vendor execution, systems, and staffing

CHF 30M → Regulatory equity reserve (required by FINMA)

CHF 9M → Working capital and operational runway

Early-stage equity investors in Monerys AG will have their tokens automatically converted into direct equity in the licensed Swiss bank upon regulatory approval.

This is not passive capital.

It’s strategic positioning — into a Swiss-regulated financial institution engineered from day one to serve tokenized finance, institutional custody, and programmable capital at scale.

Deal Structure & Investor Eligibility

Monerys AG is a purpose-built Swiss SPV created to coordinate the development and financing of the future bank.

Investors in this round will receive tokenized equity in Monerys AG, which will be automatically converted into direct equity in the licensed Swiss bank upon regulatory approval and license issuance.

✔️ Eligibility: This offering is available exclusively to accredited and institutional investors.

✔️ Legal Framework: All financial models, capital structures, and risk disclosures are outlined in our official Private Placement Memorandum (PPM) — available for download upon request.

✔️ Governance: Capital drawdowns are milestone-based, with full alignment to Swiss regulatory oversight and institutional-grade controls.

✔️ Audit Assurance: A designated independent auditor conducts quarterly audits to ensure all funds are used exclusively for approved build-out activities — with full traceability and no deviation

Milestones Ahead — And What They Unlock

This isn’t a concept. It’s a bank — being built by a team that’s done it eight times over the last decade. Every phase is mapped, every partner secured, every milestone linked to measurable progress.

“You are here” → Raise opens

Q3 2025

Finalize the business plan and complete the remaining 15% of the FINMA application (via Lloyd’s & Partners)

Q4 2025

Full license submission to FINMA

Q1-Q2 2026

Begin infrastructure implementation: core systems, staffing, physical premises, and regulatory compliance setup

Q2-Q3 2026

Final engineering, testing, and operational readiness

Q4 2026

Target license approval, equity conversion, and official bank launch

Q1 2027

Bank opens

💡 Every stage unlocks institutional value. Capital is deployed only as progress is achieved.

What Happens After Conversion?

Once the banking license is granted, Monerys tokenholders are automatically converted into direct equity shareholders of the newly licensed Swiss bank.

As equity partners, investors may benefit from:

📈 Upside potential as post-license valuation increases

💰 Dividend participation, subject to board approval

🔄 Liquidity pathways via potential secondary offerings or strategic capital events

💡 This isn’t passive capital. It’s an early stake in a future-regulated institution.

18433945_aaq_075_01-a[Converted]_edited.jpg

This raise is exclusively for accredited and institutional investors.

All projections, models, and capital structures are outlined in our Private Placement Memorandum (PPM)—available upon request and accreditation.